Published in Free Radic Biol Med on January 01, 1988
Superoxide accelerates DNA damage by elevating free-iron levels. Proc Natl Acad Sci U S A (1996) 4.29
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics (2009) 2.36
Superoxide and the production of oxidative DNA damage. J Bacteriol (1995) 1.95
Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure. Microb Ecol Health Dis (2012) 1.39
Induction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants. J Clin Invest (1990) 1.09
Low-Mr iron isolated from guinea pig reticulocytes as AMP-Fe and ATP-Fe complexes. Biochem J (1989) 1.07
Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest (1994) 0.98
A new role for heme, facilitating release of iron from the bacterioferritin iron biomineral. J Biol Chem (2010) 0.97
Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients. PLoS One (2013) 0.96
Hydroxyl radical modification of collagen type II increases its arthritogenicity and immunogenicity. PLoS One (2012) 0.95
Mitochondria and reactive oxygen species: physiology and pathophysiology. Int J Mol Sci (2013) 0.89
Prooxidant activity of transferrin and lactoferrin. J Exp Med (1990) 0.85
Essential role of an activator protein-2 (AP-2)/specificity protein 1 (Sp1) cluster in the UVB-mediated induction of the human vascular endothelial growth factor in HaCaT keratinocytes. Biochem J (2003) 0.79
Ferrous citrate up-regulates the NOS2 through nuclear translocation of NFκB induced by free radicals generation in mouse cerebral endothelial cells. PLoS One (2012) 0.79
The mechanism of melanocytes-specific cytotoxicity induced by phenol compounds having a prooxidant effect, relating to the appearance of leukoderma. Biomed Res Int (2015) 0.77
Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability. Exp Biol Med (Maywood) (2016) 0.75
Estimation of the postmortem duration of mouse tissue by electron spin resonance spectroscopy. J Toxicol (2011) 0.75
Ferritin and desferrioxamine attenuate xanthine oxidase-dependent leak in isolated perfused rat lungs. Inflammation (2002) 0.75
Fever in neutropenic patients treated with GM-CSF representing enhanced host defence. Lancet (1992) 2.59
Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum (1979) 2.23
[Rheumatoid arthritis and anemia; various aspects concerning prevalence, pathogenesis, diagnosis and therapy]. Ned Tijdschr Geneeskd (1992) 2.02
Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome. Clin Chim Acta (1984) 1.83
Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases. J Clin Invest (1984) 1.76
Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial. Br J Rheumatol (1996) 1.51
p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem Biophys Res Commun (1997) 1.42
Analytical and clinical implications of soluble transferrin receptors in serum. Eur J Clin Chem Clin Biochem (1996) 1.41
Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J Immunol (1998) 1.39
[Iron deficiency, a simple diagnosis?]. Ned Tijdschr Geneeskd (1993) 1.38
Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis (1982) 1.35
Hepatic phosphorylase deficiency. Its differentiation from other hepatic glycogenoses. Arch Dis Child (1974) 1.31
Detection of antibodies to DNA by radioimmunoassay and immunofluorescence. Scand J Rheumatol Suppl (1975) 1.30
Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. Cancer Res (1996) 1.28
Structure, function and clinical significance of transferrin receptors. Clin Chem Lab Med (1999) 1.28
Human erythrocyte pyruvate kinase. Its purification and some properties. Biochim Biophys Acta (1971) 1.25
Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis (1986) 1.25
Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation (1995) 1.22
Hormonal control of glycogenolysis in parenchymal liver cells by Kupffer and endothelial liver cells. J Biol Chem (1988) 1.21
Detection of anti-dsDNA as diagnostic tool. Ann Rheum Dis (1981) 1.21
Immune complex detection by immunofluorescence on polymorphonuclear leucocytes. Clin Exp Immunol (1977) 1.21
Biochemical, immunological, and cell genetic studies in glycogenosis type II. Am J Hum Genet (1978) 1.20
The biology of transferrin. Clin Chim Acta (1990) 1.19
Regulation of iron metabolism in the acute-phase response: interferon gamma and tumour necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients. Eur J Clin Invest (1998) 1.19
Interleukin-1-induced interleukin-6 is required for the inhibition of proteoglycan synthesis by interleukin-1 in human articular cartilage. Arthritis Rheum (1990) 1.17
Acquired, transient factor X (Stuart factor) deficiency in patient with mycoplasma pneumonial infection. Scand J Haematol (1979) 1.15
Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr (1999) 1.14
Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Q J Med (1991) 1.11
Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness. Ann Rheum Dis (1990) 1.08
Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine. Circulation (1988) 1.08
Lipid peroxidation of human erythrocyte ghosts induced by organic hydroperoxides. Biochim Biophys Acta (1983) 1.07
Erythrocyte antioxidant enzymes in patients with RA. J Rheumatol (1989) 1.07
Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway. J Immunol Methods (1993) 1.05
The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis Rheum (1998) 1.05
Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid. Arthritis Rheum (1984) 1.04
Endotoxin stimulates glycogenolysis in the liver by means of intercellular communication. J Biol Chem (1988) 1.04
Optimized separation and quantitation of serum and cerebrospinal fluid transferrin subfractions defined by differences in iron saturation or glycan composition. Adv Exp Med Biol (1994) 1.02
Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas. Cancer Res (1993) 1.02
The binding of iron to transferrin and to other serum components at different degrees of saturation with iron. Clin Chim Acta (1972) 1.02
Conditioned media of Kupffer and endothelial liver cells influence protein phosphorylation in parenchymal liver cells. Involvement of prostaglandins. Biochem J (1988) 1.00
Possible involvement of the lipid-peroxidation product 4-hydroxynonenal in the formation of fluorescent chromolipids. Biochem J (1986) 0.99
Urinary beta 2 microglobulin in upper and lower urinary-tract infections. Lancet (1979) 0.99
The interaction in vivo of transferrin and asialotransferrin with liver cells. Biochem J (1987) 0.99
Hormone-induced changes in pyruvate kinase. Effects of glucagon and starvation. Eur J Biochem (1977) 0.99
Anti-heparan sulphate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations. Clin Exp Immunol (1990) 0.98
CCC.UGA: a new site of ribosomal frameshifting in Escherichia coli. Gene (1994) 0.98
Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis. Eur J Clin Invest (1992) 0.98
The use of leucocytes as an aid in the diagnosis of glycogen storage disease type II (Pompe's disease). Clin Chim Acta (1974) 0.98
Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. Cancer Res (1997) 0.98
Low molecular weight iron and the oxygen paradox in isolated rat hearts. J Clin Invest (1992) 0.98
Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. J Cardiovasc Pharmacol (1993) 0.98
Prostaglandin D2 mediates the stimulation of glycogenolysis in the liver by phorbol ester. Biochem J (1988) 0.97
Complement (C3) metabolism in systemic lupus erythematosus in relation to the disease course. Rheumatol Int (1986) 0.97
Human serum sialo transferrins in diseases. Clin Chim Acta (1987) 0.96
Mechanism of glucagon stimulation of fructose-1,6-bisphosphatase in rat hepatocytes. Involvement of a low-Mr activator. FEBS Lett (1986) 0.96
Superoxide production by polymorphonuclear leucocytes in rheumatoid arthritis and osteoarthritis: in vivo inhibition by the antirheumatic drug piroxicam due to interference with the activation of the NADPH-oxidase. Ann Rheum Dis (1986) 0.96
Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis (1989) 0.95
Some properties of human liver acid alpha-glucosidase. Biochim Biophys Acta (1977) 0.95
Microheterogeneity of human serum transferrin: a biological phenomenon studied by isoelectric focusing in immobilized pH gradients. Electrophoresis (1988) 0.95
Prevention of postischemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant (+)-cyanidanol-3. Circulation (1989) 0.95
Evidence against the involvement of multiple radical generating sites in the expression of the vascular cell adhesion molecule-1. Free Radic Res (1998) 0.93
The relationship between serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosus. Clin Immunol Immunopathol (1993) 0.93
Transferrin microheterogeneity in rheumatoid arthritis. Relation with disease activity and anemia of chronic disease. Rheumatol Int (1992) 0.92
Diurnal and nocturnal variations of the serum iron in normal subjects. Clin Chim Acta (1973) 0.91
Intracellular and extracellular sulphydryl levels in rheumatoid arthritis. Ann Rheum Dis (1986) 0.91
Absence of IgA nephropathy in patients with ankylosing spondylitis. Rheumatol Int (1986) 0.91
Expression of the activation antigen CD27 in rheumatoid arthritis. Clin Immunol Immunopathol (1996) 0.91
On the mechanisms of photochemical reductions of FAD and FAD-dependent flavoproteins. Eur J Biochem (1967) 0.91
Iron chelators may enhance erythropoiesis by increasing iron delivery to haematopoietic tissue and erythropoietin response in iron-loading anaemia. Acta Haematol (1993) 0.91
Manganese-induced hydroxyl radical formation in rat striatum is not attenuated by dopamine depletion or iron chelation in vivo. Exp Neurol (1996) 0.91
Analysis of iron-binding components in the low molecular weight fraction of rat reticulocyte cytosol. Int J Biochem (1985) 0.90
Difference in the effect of glucagon and starvation upon L-type pyruvate kinase from rat liver. Eur J Biochem (1978) 0.90
Influence of cumene hydroperoxide and 4-hydroxynonenal on the glutathione metabolism during in vitro ageing of human skin fibroblasts. Eur J Biochem (1987) 0.90
Lymphocytotoxic antibodies in SLE: a review of the literature. Clin Rheumatol (1994) 0.90
Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease. J Rheumatol (1997) 0.90
Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset. Ann Rheum Dis (1996) 0.90
Absence of severe systemic toxicity after leakage-controlled isolated limb perfusion with tumor necrosis factor-alpha and melphalan. Ann Surg Oncol (1999) 0.89
Distribution of L- and M-type pyruvate kinase between parenchymal and Kupffer cells of rat liver. Biochim Biophys Acta (1972) 0.89
The relation of erythrocyte porphyrins to haemoglobin, haematocrit, transferrin and serum iron. Clin Chim Acta (1974) 0.89
Clinical evaluation of a modified ELISA, using photobiotinylated DNA, for the detection of anti-DNA antibodies. J Immunol Methods (1994) 0.89
Intraarticular ferritin-bound iron in rheumatoid arthritis. A factor that increases oxygen free radical-induced tissue destruction. Arthritis Rheum (1986) 0.89
Anti-dsDNA and complement profiles in systemic lupus erythematosus. Neth J Med (1981) 0.88